1. Home
  2. CCCS vs RGC Comparison

CCCS vs RGC Comparison

Compare CCCS & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCCS
  • RGC
  • Stock Information
  • Founded
  • CCCS 1980
  • RGC 2014
  • Country
  • CCCS United States
  • RGC Hong Kong
  • Employees
  • CCCS N/A
  • RGC N/A
  • Industry
  • CCCS Computer Software: Prepackaged Software
  • RGC Medicinal Chemicals and Botanical Products
  • Sector
  • CCCS Technology
  • RGC Health Care
  • Exchange
  • CCCS Nasdaq
  • RGC Nasdaq
  • Market Cap
  • CCCS 5.8B
  • RGC 6.6B
  • IPO Year
  • CCCS N/A
  • RGC 2021
  • Fundamental
  • Price
  • CCCS $9.38
  • RGC $17.10
  • Analyst Decision
  • CCCS Buy
  • RGC
  • Analyst Count
  • CCCS 7
  • RGC 0
  • Target Price
  • CCCS $11.43
  • RGC N/A
  • AVG Volume (30 Days)
  • CCCS 5.4M
  • RGC 201.2K
  • Earning Date
  • CCCS 10-27-2025
  • RGC 10-24-2025
  • Dividend Yield
  • CCCS N/A
  • RGC N/A
  • EPS Growth
  • CCCS N/A
  • RGC N/A
  • EPS
  • CCCS 0.00
  • RGC N/A
  • Revenue
  • CCCS $996,961,000.00
  • RGC N/A
  • Revenue This Year
  • CCCS $13.57
  • RGC N/A
  • Revenue Next Year
  • CCCS $9.04
  • RGC N/A
  • P/E Ratio
  • CCCS $3,176.69
  • RGC N/A
  • Revenue Growth
  • CCCS 9.60
  • RGC N/A
  • 52 Week Low
  • CCCS $8.14
  • RGC $0.09
  • 52 Week High
  • CCCS $12.88
  • RGC $83.60
  • Technical
  • Relative Strength Index (RSI)
  • CCCS 47.19
  • RGC 62.79
  • Support Level
  • CCCS $8.96
  • RGC $15.29
  • Resistance Level
  • CCCS $9.44
  • RGC $16.39
  • Average True Range (ATR)
  • CCCS 0.21
  • RGC 0.94
  • MACD
  • CCCS -0.02
  • RGC 0.20
  • Stochastic Oscillator
  • CCCS 48.28
  • RGC 97.24

About CCCS CCC Intelligent Solutions Holdings Inc.

CCC Intelligent Solutions Holdings Inc is a provider of cloud, mobile, AI, telematics, hyperscale technologies and applications for the property and casualty insurance economy. The company's SaaS platform connects trading partners, facilitates commerce, and supports mission-critical, and AI-enabled digital workflows. It operates in a single segment being Domestic segment which provides SAAS platform for the P&C insurance economy and derives revenues from providing customers with software subscriptions to the platform in addition to providing professional services and non-software services. The company has its presence in United States and China. Majority of the revenue is generated from United States.

About RGC Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

Share on Social Networks: